MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,325 | -4.7% | 75 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $18,170 | -100.0% | 75 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $87,096,770 | +4237.5% | 300,075 | +1166.1% | 21.01% | +6927.4% |
| Q4 2021 | $2,008,000 | +6.2% | 23,700 | 0.0% | 0.30% | +124.8% |
| Q3 2021 | $1,890,000 | -17.9% | 23,700 | +0.2% | 0.13% | -28.5% |
| Q2 2021 | $2,303,000 | -16.8% | 23,654 | 0.0% | 0.19% | +100.0% |
| Q1 2021 | $2,768,000 | +5.2% | 23,654 | 0.0% | 0.09% | -19.8% |
| Q4 2020 | $2,630,000 | -84.0% | 23,654 | -82.9% | 0.12% | -90.3% |
| Q3 2020 | $16,451,000 | +14.2% | 138,554 | +8.9% | 1.19% | +3.7% |
| Q2 2020 | $14,411,000 | +435.1% | 127,254 | +215.5% | 1.15% | +465.0% |
| Q1 2020 | $2,693,000 | -79.6% | 40,334 | -72.1% | 0.20% | -90.5% |
| Q4 2019 | $13,190,000 | – | 144,770 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |